Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMERICAN STORES/LUCKY MERGER FURTHER DELAY POSSIBLE

Executive Summary

AMERICAN STORES/LUCKY MERGER FURTHER DELAY POSSIBLE if the Supreme Court decides to consider the case when it reconvenes Oct. 2. On Aug. 22, Justice Sandra Day O'Connor issued an order blocking the $ 2.5 bil. merger of the two California supermarket pharmacy chains at the request of California Attorney General John Van de Kamp. His office has been fighting the merger in federal court since September on antitrust grounds, although the deal was cleared by the Justice Department and the Federal Trade Commission last year. American Stores agreed to purchase Lucky in June 1988 with the intention of combining American's Alpha Beta chain stores into a single chain operating under the Lucky name ("The Pink Sheet," May 23, 1988, T&G-6). Alpha Beta and Lucky together operate 550 stores. Lucky is currently California's largest supermarket chain, and Alpha Beta is fourth largest. Lucky has pharmacies in 97 of its 483 food outlets. A Los Angeles federal court concurred in September 1988 with the state that the merger should not be consummated. However, in March of the year, an appeals court ordered the Attorney General's office to post a $ 16.3 mil. bond to cover American Stores' potential losses during the appeals process. That bond requirement was the catalyst for Van de Kamp's petitioning for U.S. Supreme Court intervention. He argued that under the circuit court order, the case would be dropped because his office could post only a nominal amount due to budgetary constraints. Justice O'Connor's original order made no mention of the bond, apparently clearing the way for the state to seek high court review. However, the following day she amended her order to require that a bond be posted. O'Connor's action sends the matter back to Los Angeles federal court, which will determine the amount of the bond. If the original amount is reinstated the Attorney General will be forced to drop the suit, according to his office. A hearing has been scheduled for Aug. 29. A spokesperson for American Stores said the supermarket/pharmacy chain would be represented by attorney Rex E. Lee of the D.C. law firm, Sidney Austin, if the high court takes the issue under consideration. "If the suit is dropped or decided in its favor, the company expects that the legal process of the merger could be rapidly concluded," the spokesperson said.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS016125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel